CKD-11101 Phase 3 SC Study

NCT03431623 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

248

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia of Chronic Kidney Disease

Interventions

BIOLOGICAL: CKD-11101(Darbepoetin alfa)
BIOLOGICAL: NESP(Darbepoetin alfa)

Sponsor

Chong Kun Dang Pharmaceutical